Elite athletes live longer than the general population

This study aimed to perform a meta-analysis of cohort studies aimed at providing an accurate overview of mortality in elite athletes. English-language scientific articles available in Medline and Web of Science databases following the recommendations of the Meta-analyses Of Observational Studies in Epidemiology group were reviewed. A search was conducted for publications on longevity and professional or elite athletes (with no restriction on the starting date and up to March 31, 2014). Ten studies, including data from a total of 42,807 athletes (707 women), met all inclusion criteria. The all-cause pooled standard mortality ratio (SMR) was 0.67 (95% CI, 0.55-0.81; P<.001) with no evidence of publication bias (P=.24) but with significant heterogeneity among studies (I(2)=96%; Q=224.46; P<.001). Six studies provided data on cardiovascular disease (CVD) and 5 on cancer (in a total of 35,920 and 12,119 athletes, respectively). When only CVD was considered as a cause of mortality, the pooled SMR was 0.73 (95% CI, 0.65-0.82; P<.001) with no evidence of bias (P=.68) or heterogenity among studies (I(2)=38%; Q=8.07; P=.15). The SMR for cancer was 0.60 (95% CI, 0.38-0.94; P=.03) without andy evidence of bias (P=.20) despite a significant heterogeneity (I(2)=91%; Q=44.21; P<.001).

The evidence available suggests that top-level athletes live longer than the general population and have a lower risk of 2 major causes of mortality, namely, CVD and cancer.

Cervical Spine Course

Establish what is fact and fiction when it comes to neck pain. Myth bust the cervical spine with the help of experts and colleagues around the world.

Speak your mind

Your email will not be published.